Discontinued Operations - Sale of Infusionz to Bloomios (Details Narrative) - USD ($)	Mar. 31, 2024	Jun. 30, 2023	Oct. 28, 2022
Common stock, 1,247,402 shares valued at $4.81 per common share, the calculated closing price on October 21, 2022.	$ 20,909	$ 20,216
Discontinued Operations [Member]
Accounts receivable		845,443
Original principal amount			$ 5,500,000
Series D Convertible Preferred Stock, value			$ 8,500,000
Series D Convertible Preferred Stocks			85,000
Senior secured convertible debenture			$ 4,500,000
Reserve	$ 1,179,498	$ 931,613
Original principal amount, after OID			779,117
Common stock purchase warrant			2,853,910
Common stock, 1,247,402 shares valued at $4.81 per common share, the calculated closing price on October 21, 2022.			8,500,000
Valuation allowance			$ 8,500,000